Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has bee ...

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise ...

LOS ANGELES, CA / ACCESS Newswire / February 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of ...

LOS ANGELES, CA / ACCESS Newswire / February 19, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of ...

Despite a mixed fourth-quarter revenue performance, British pharmaceutical giant GSK remains optimistic about its long-term growth prospects, particularly with its ambitious revenue target for 2031.

About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate ...

Why: Rosen Law Firm, a global investor rights ... study that implicated GSK's liability to Zantac users. When the true details entered the market, the lawsuit claims that investors suffered ...

In October, when GSK agreed to a $2.2 billion settlement to resolve approximately 80,000 lawsuits brought by users of Zantac, it appeared that the drugmaker’s legal issues with the heartburn ...

comes from crisis public relations firm Street Relations and its owner, Jed Wallace, who accuse Lively of defamation in a complaint she filed in December 2024. This lawsuit adds fuel to the ...

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) between ...